Author

Yibin Feng

Professor, The University of Hong Kong - Cited by 23,476 - Chinese Medicine - cancer and metabolic diseases

Biography

Mr. Yibin Feng is a assistant professor in the department of Medicine, School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China. He published 20 articles related to Chinese Medicine, cancer and metabolic diseases.
Title
Cited by
Year
Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management
G Tang, S Li, C Zhang, H Chen, N Wang, Y FengActa Pharmaceutica Sinica B 11 (9), 2749-2767, 2021202
83
2021
Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
Y Lu, YT Chan, HY Tan, C Zhang, W Guo, Y Xu, R Sharma, ZS Chen, ...Journal of Experimental & Clinical Cancer Research 41 (1), 1-17, 2022202
52
2022
Green tea and epigallocatechin gallate (EGCG) for the management of nonalcoholic fatty liver diseases (NAFLD): Insights into the role of oxidative stress and antioxidant mechanism
G Tang, Y Xu, C Zhang, N Wang, H Li, Y FengAntioxidants 10 (7), 1076, 2021202
45
2021
Gallic acid and diabetes mellitus: its association with oxidative stress
Y Xu, G Tang, C Zhang, N Wang, Y FengMolecules 26 (23), 7115, 2021202
37
2021
Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
Z Zhong, CT Vong, F Chen, H Tan, C Zhang, N Wang, L Cui, Y Wang, ...Medicinal Research Reviews 42 (3), 1246-1279, 2022202
33
2022
The toxicology and detoxification of Aconitum: traditional and modern views
YT Chan, N Wang, Y FengChinese Medicine 16, 1-14, 2021202
24
2021
Transcriptional profiling and machine learning unveil a concordant biosignature of type I interferon-inducible host response across nasal swab and pulmonary tissue for COVID-19 …
C Zhang, YG Feng, C Tam, N Wang, Y FengFrontiers in immunology 12, 7331, 2021202
17
2021
GPC2 is a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
G Chen, D Luo, N Zhong, D Li, J Zheng, H Liao, Z Li, X Lin, Q Chen, ...Frontiers in Immunology 13, 857308, 2022202
16
2022
Elderberry (Sambucus nigra L.): Bioactive Compounds, Health Functions, and Applications
D Liu, XQ He, DT Wu, HB Li, YB Feng, L Zou, RY GanJournal of Agricultural and Food Chemistry 70 (14), 4202-4220, 2022202
16
2022
Network Pharmacology–Based Analysis and Experimental Exploration of Antidiabetic Mechanisms of Gegen Qinlian Decoction
Y Xu, J Huang, N Wang, HY Tan, C Zhang, S Li, G Tang, Y FengFrontiers in Pharmacology 12, 649606, 2021202
11
2021
Broad‐spectrum antiviral activity of Spatholobus suberectus Dunn against SARS‐CoV‐2, SARS‐CoV‐1, H5N1, and other enveloped viruses
Q Liu, KY Kwan, T Cao, B Yan, K Ganesan, L Jia, F Zhang, C Lim, Y Wu, ...Phytotherapy Research 36 (8), 3232-3247, 2022202
10
2022
The role and mechanisms of selenium supplementation on fatty liver-associated disorder
L Xu, Y Lu, N Wang, Y FengAntioxidants 11 (5), 22, 2022202
9
2022
Bioactivities and mechanism of actions of dendrobium officinale: a comprehensive review
X Xu, C Zhang, N Wang, Y Xu, G Tang, L Xu, Y FengOxidative Medicine and Cellular Longevity 2022, 2022202
9
2022
Circulating tumor cells in the early detection of human cancers
Z Feng, Y Feng, N WangHandbook of Cancer and Immunology, 1-20, 2022202
8
2022
Progress in clinical research on the integration of Chinese and Western medicines for treating primary liver cancer
K Liu, H Li, J Duan, X Chen, X Yu, X Wang, M Liu, B Li, M Li, Y Feng, ...Journal of Traditional Chinese Medical Sciences 8 (3), 13-185, 2021202
7
2021
Adjunctive berberine reduces antipsychotic‐associated weight gain and metabolic syndrome in patients with schizophrenia: a randomized controlled trial
MY Chan, Z Qin, SC Man, M Lam, WH Lai, RMK Ng, CK Lee, TL Wong, ...Psychiatry and Clinical Neurosciences 6 (3), -85, 2022202
7
2022
Efficacy and safety of Chinese herbal medicine on treatment of breast cancer: A meta-analysis of randomized controlled trials
VWT Ho, HY Tan, W Guo, S Li, N Wang, W Meng, T So, ECL Yu, Y FengThe American Journal of Chinese Medicine 49 (07), 1557-1575, 2021202
6
2021
CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives
YT Chan, Y Lu, J Wu, C Zhang, HY Tan, Z Bian, N Wang, Y FengTheranostics 12 (7), 3329, 2022202
6
2022
Berberine suppresses advanced glycation end products‐associated diabetic retinopathy in hyperglycemic mice
N Wang, L Wang, C Zhang, HY Tan, Y Zhang, Y FengClinical and Translational Medicine 11 (11), 2021202
4
2021
Systematic Review with Meta-Analysis: Effectiveness and Safety of Acupuncture as Adjuvant Therapy for Side Effects Management in Drug Therapy-Receiving Breast Cancer Patients
YT Chan, N Wang, CW Tam, HY Tan, Y Lu, T So, E Chau-Leung Yu, ...Evidence-Based Complementary and Alternative Medicine 2021, 2021202
4
2021

Referred From: https://scholar.google.com/citations?hl=en&user=2ODfxvQAAAAJ

Cited by
Citations 23476
h-index 52
i10-index 139
Recommended Journals
Open Access Journals